image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Synergy Healthcare - Increases bid for Isotron

January 2007

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SYR
  • Price:
  • 660p
Synergy Healthcare has once again produced a strong set of results for the six months ended 1 October with turnover increasing 33% to £66.9m and pretax profit rising 19% to £6.2m. Adjusted earnings rose 23% to 13.0p. Synergy’s Patient Care division, which comprises the linen management and ex-Shiloh businesses, led the way with sales increasing 35% to £52m on the back of an increase in its market share by 2% to 16% thanks to new contract wins. Synergy has also beefed-up its woundcare and infection control services through the acquisition of licences to use Aircleanse, an air decontamination system and Byotrol, an antimicrobial technology. Synergy’s Netherlands subsidiary, LTS, experienced a 6% increa ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X